Accretive Acquisitions Chart - slide #20 shows major moves in the pipeline that would generate a lot of growth-revenue projections
Revenue Forecast via Insurance Outlets
2008 Global recession - Healthcare Policy doesn't pay 2009 Global recession - Healthcare Policy doesn't pay
Strong Organic Sales Growth Predicted Yr.....|Dom..|.Int'l....|.Total....| 2010 |$22M.|$4.8M.|.$25M...| Healthcare Policy Change pays for stem storage 2011 |$25M.|$5.0M.|.$30M...| Healthcare Policy Change pays for stem storage
These "organic" growth projections are showing 4 to 5 times previous yrs historic revenues. So, where does it go with Nat'l Health care coverage which was not formulated in thes projections? Maybe 10 - 20 times the amount of growth presented due to volume sales. Add in TRICARE, BCBS, UnitedHealth and the insurance companies paying on a "limited basis" the medical cryo-store and these projections are way low IMO because these likely didn't factor in the brisk pace stem cell advancement cures coming to fruition all together!